Literature DB >> 19525584

Characteristics of mood disorders in Japanese patients with medication-overuse headache.

Yoshiaki Kaji1, Koichi Hirata.   

Abstract

OBJECTIVE: The importance of psychiatric comorbidity in migraine has long been recognized. There is a growing body of evidence that these psychiatric comorbidities share diverse epidemiological properties, pathophysiological mechanisms, and treatment response. The prevalence of psychiatric comorbidities is high in patients with medication-overuse headache (MOH).
METHODS: To understand the characteristics of mood disorders in MOH in Japanese patients, we studied and evaluated the characteristics of psychiatric comorbidities in MOH.
RESULTS: The results suggested that mood disorders in MOH are similar to those in endogenous depression but different from those of secondary mood disorders associated with other diseases. Suspicion of depression and intervention are essential for providing medical care for patients with MOH.
CONCLUSION: Affective disorders diagnosed in migraine patients might later progress to MOH. In contrast, migraine patients without MOH and healthy subjects had a similar prevalence of mood disorders.

Entities:  

Mesh:

Year:  2009        PMID: 19525584     DOI: 10.2169/internalmedicine.48.1884

Source DB:  PubMed          Journal:  Intern Med        ISSN: 0918-2918            Impact factor:   1.271


  3 in total

1.  Predictive index for the onset of medication overuse headache in migraine patients.

Authors:  T Onaya; M Ishii; H Katoh; S Shimizu; H Kasai; M Kawamura; Y Kiuchi
Journal:  Neurol Sci       Date:  2013-01       Impact factor: 3.307

2.  Psychiatric comorbidity and suicide risk in patients with chronic migraine.

Authors:  Maurizio Pompili; Gianluca Serafini; Daniela Di Cosimo; Giovanni Dominici; Marco Innamorati; David Lester; Alberto Forte; Nicoletta Girardi; Sergio De Filippis; Roberto Tatarelli; Paolo Martelletti
Journal:  Neuropsychiatr Dis Treat       Date:  2010-04-07       Impact factor: 2.570

3.  Association between the G252A Tumor Necrosis Factor-β Gene Polymorphism and Medication-Overuse Headache.

Authors:  Masakazu Ishii; Tomomi Onaya; Hirotaka Katoh; Yuji Kiuchi; Hideyo Kasai; Mitsuru Kawamura; Shunichi Shimizu
Journal:  J Clin Neurol       Date:  2012-12-21       Impact factor: 3.077

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.